The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...
Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...
Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...
Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.
AstraZeneca shares were up about 3.5% Friday after the company said its drug for COPD, a deadly lung disease often caused by smoking, slowed patients' symptoms in two large trials. The drug, ...
Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.
In a phase 2 trial, treatment with sotatercept shows reduced pulmonary vascular resistance and heart outcomes in patients ...
Avalyn Pharma's IPO aims to fund inhaled IPF therapies as AP01 shows positive Phase II results. Read the full analysis here.
The acquisition brings together the gold standard for continuous ambulatory cough monitoring and lung sound analysis ...
E2 raises $80M to scale Hēlo®, improving pulmonary embolism treatment with faster, safer, and more efficient procedures.
Peer-reviewed study confirming strong predictive performance of patient-specific lung digital twins, validated against ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results